Research programme: vanilloid receptor antagonists - NovartisAlternative Names: TRPV1 antagonists- Novartis; TRVPV-1 antagonists - Novartis; VR-1 antagonists - Novartis
Latest Information Update: 16 Jul 2010
At a glance
- Originator Novartis
- Mechanism of Action TRPV cation channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 16 Jul 2010 Discontinued - Preclinical for Neuropathic pain in Switzerland (PO)
- 16 Jul 2010 Discontinued - Preclinical for Neuropathic pain in United Kingdom (PO)
- 27 Jun 2006 Preclinical trials in Neuropathic pain in Switzerland (PO)